BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Apoptosis
,
Obesity
,
Pancreas
,
Anticancer prodrugs
,
Clofibrate
,
rs7903146
,
DRD2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Pralidoxime chloride
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Liver Pharmacology and Xenobiotic Response Repertoire
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Repeated pulse intramuscular injection of pralidoxime chloride in severe acute organophosphorus pest…
Stripping voltammetric determination of pyridine-2-aldoxime methochloride at the iron(III) doped zeo…
Oxidative mechanisms for the biotransformation of 1-methyl-1,6-dihydropyridine-2-carbaldoxime to pra…
Different therapeutic efficacy of pralidoxime chloride PAM-Cl on AChE against acute toxicity of meth…
Therapeutic efficacy of pralidoxime chloride on acute dichlorvos poisoning].
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for Pralidoxime chloride
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ